VAERS Explorer
Back to explore

Report #2872658

Received Nov 14, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
KS
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
PNC21PNEUMO (CAPVAXIVE)MERCK & CO. INC.UNK——
PNC21PNEUMO (CAPVAXIVE)MERCK & CO. INC.UNK——

Symptoms (2)

Extra dose administeredNo adverse event

Symptom narrative

Pharmacist reported that a patient told her that she has had two doses of CAPVAXIVE and would like to get a third dose.; No additional AE.; Information has been received from Business Partner on 11-Nov-2025. This spontaneous report was received from a/an Pharmacist and refers to a(n) female patient of unknown age. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, the patient started therapy with unknown dosage. On an unknown date, the patient started therapy with Pneumococcal 21-valent Conjugate Vaccine (Dose #1.), (lot # and expiration date were not reported). On an unknown date, the patient started therapy with Pneumococcal 21-valent Conjugate Vaccine (Dose #2.), (lot # and expiration date were not reported). The patient started therapy with for the treatment of Prophylaxis. The patient started therapy with Pneumococcal 21-valent Conjugate Vaccine for the treatment of Prophylaxis. On an unknown date, the patient experienced Pharmacist reported that a patient told her that she has had two doses of CAPVAXIVE and would like to get a third dose.. On an unknown date, the patient experienced No additional AE.. At the reporting time, the outcome of Pharmacist reported that a patient told her that she has had two doses of CAPVAXIVE and would like to get a third dose. and No additional AE. was unknown. The action taken with Pneumococcal 21-valent Conjugate Vaccine was reported as not applicable.